Study guide
11.2 Internal Transport & Storage
PTCB Hazardous Drug Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
0.1 Exam Facts, Format & Eligibility 0.2 Content Outline, Scoring & Registration 0.3 USP <800> Big Picture & How to Use This Guide
2 USP <800> Program Administration
1.1 USP <800> Scope, Purpose & Enforcement 1.2 The NIOSH Hazardous Drug List (2024 Update) 1.3 Assessment of Risk 1.4 Designated Person, SOPs & the Hierarchy of Controls
3 Training, Compliance & Recordkeeping
2.1 Training Requirements & Medical Surveillance 2.2 Hazard Communication, SDS & OSHA Requirements 2.3 Recordkeeping & Professional Guidelines
4 Primary Engineering Controls
3.1 Containment Primary Engineering Controls (C-PEC): BSCs & CACIs 3.2 Closed System Transfer Devices (CSTDs) 3.3 Nonsterile Controls and the C-SCA Distinction
5 Secondary Engineering Controls & Facility Design
4.1 Containment Secondary Engineering Controls (C-SEC): Negative Pressure & Air Exchange 4.2 Facility Layout: Storage, Unpacking & Sink Placement 4.3 Certification, ISO Classes & Emergency Equipment
6 Facility Cleaning Procedures
5.1 The Four-Step Cleaning Process 5.2 Wipe Sampling & Action Levels 5.3 Hazardous Waste Disposal & RCRA
7 Spill Response & Cleaning PPE
6.1 Spill Kits & Spill Response Procedures 6.2 PPE During Cleaning: Glove Change Frequency & Disposal
8 Dispensing & the Compounding Interface
7.1 USP <795>/<797> Interface for Hazardous Drugs 7.2 High-Risk Oral Hazardous Drugs 7.3 Tablet Splitting & Crushing Restrictions
9 Counting, Packaging & Patient Counseling
8.1 Counting, Packaging & Dedicated Equipment 8.2 Patient Counseling & Unit-Dose Labeling
10 PPE: Gloves, Gowns & Task-Based Selection
9.1 ASTM D6978 Chemotherapy Gloves & Double Gloving 9.2 Chemo Gowns & Gown Change Frequency 9.3 Task-Based PPE Selection
11 Respiratory Protection, Eye Protection & PPE Sequencing
10.1 Respiratory & Eye/Face Protection 10.2 Donning & Doffing Sequence
12 Transport & Receiving
11.1 Receiving Hazardous Drug Shipments 11.2 Internal Transport & Storage 11.3 Damaged/Leaking Shipments & Chain of Custody
13 Exam Readiness & Final Review
12.1 Domain-by-Domain Quick Review 12.2 Common Exam Traps & Final Checklist
11.2 Internal Transport & Storage
Key Takeaways Explain This Topic AI
HDs travel within a facility in sealed, puncture-resistant secondary containers — especially liquids and injectables — routed to minimize the number of personnel and transit points involved.
Pneumatic tube systems are generally avoided for HD transport due to breakage, leak, and aerosolization risk; where used at all, they require specific validation and sealed HD-rated carriers per facility SOP.
HD storage must be physically separate from non-HD inventory, typically in a negative-pressure area with at least 12 air changes per hour (ACPH) — the nonsterile-area figure, since storage is never itself a compounding activity.
Sterile HD compounding buffer rooms require a higher air-exchange rate (30 ACPH) than HD storage/nonsterile-compounding areas (12 ACPH) — the two figures are not interchangeable.
Antineoplastic HDs are often further segregated from other HD categories within storage, and storage areas require clear signage/labeling.
Last updated: July 2026
Internal Transport & Storage
Once an HD shipment clears receiving, it still has to move — from the receiving area to HD storage, from storage to a compounding room, and sometimes from compounding to a nursing unit or infusion clinic. Each of those transitions is a transit point, and every transit point is an opportunity for a container to be dropped, punctured, or opened accidentally. USP <800> addresses this risk through two related requirements: how HDs move within a facility, and how they are stored once they arrive at their destination. Both show up on the PTCB Hazardous Drug Management exam as scenario questions built around a specific container type, a specific number of transit points, or a specific storage layout.
Principles of Internal HD Transport
The guiding idea behind internal transport is straightforward: an HD in transit should be no more likely to break, leak, or release vapor than an HD sitting still. That means:
Sealed, puncture-resistant secondary containers. HDs — especially liquids and injectables — should travel inside containers designed to contain a break or leak, not just the primary vial or bag alone.
Minimizing personnel and transit points. Every additional hand-off and every additional stop along the route is another chance for a container to be dropped, jostled, or mishandled. Facilities should route HD transport to touch as few people and as few intermediate stops as the workflow allows.
- Transport Element Requirement
- Container Sealed, puncture-resistant secondary container (critical for liquids/injectables)
- Route Minimizes the number of personnel and transit points involved
- Labeling Clearly identifies HD contents so anyone handling the container recognizes it
- Pneumatic Tube Systems: Generally Avoided
Many facilities use pneumatic tube systems to move medications quickly between departments — but HDs are the exception, not the rule, for this technology. The forces involved in tube transport (rapid acceleration, impact at the receiving station) create real breakage, leak, and aerosolization risk for an HD container, which is unacceptable for a drug class where inhalation and dermal exposure are the primary safety concerns.
As a result, facilities generally avoid pneumatic tubes for HD transport . Where a facility does use pneumatic tubes for HDs at all, it requires:
Specific validation of the tube system for HD transport, rather than a general assumption that the system already works acceptably for other medications
Sealed, HD-rated carriers designed to contain a break or leak inside the tube
A facility SOP documenting exactly which HDs, if any, are approved for tube transport and under what container requirements
Exam Tip: If a scenario asks whether a chemotherapy vial should go through a facility's pneumatic tube system, the safer and generally correct answer is no — hand-deliver it in a sealed, puncture-resistant secondary container instead, unless the question explicitly states the tube system has been validated for HDs and uses HD-rated carriers.
HD Storage Requirements
Storage is where HDs sit between transport events, and it carries its own containment requirements:
Requirement Detail
Separation from non-HD inventory HDs are stored in dedicated shelving or a dedicated area, never mixed with the general drug stock
Negative pressure HD storage areas typically sit in a negative-pressure space with at least 12 air changes per hour (ACPH) — the nonsterile-area figure, since storage itself is not a compounding activity
Category segregation Antineoplastic HDs are often further segregated from other HD categories (e.g., non-antineoplastic and reproductive-risk-only drugs), per facility policy
Signage/labeling Storage areas and shelving must be clearly marked to alert personnel that HD contents require special handling
Note the ACPH figure carefully: 12 ACPH applies to nonsterile HD storage and compounding areas (C-SCA). It is not the figure for sterile HD compounding buffer rooms, which require a higher air-exchange rate of 30 ACPH , because those rooms carry the added burden of maintaining ISO Class 7 sterility alongside containment. Since storage is never itself a compounding activity, HD storage areas correctly use the 12 ACPH nonsterile figure — do not treat 12 ACPH as a universal HD number that also covers sterile compounding spaces.
Exam Scenario
A pharmacy is evaluating whether to route chemotherapy vials from the receiving area to the infusion clinic through its existing pneumatic tube system, which is already used for non-hazardous medications. The correct call, absent specific validation of the tube system for HD use and HD-rated sealed carriers, is to avoid the pneumatic tube and instead hand-transport the vials in a sealed, puncture-resistant secondary container, using the fewest personnel and stops the workflow allows. Once the vials reach the clinic, they should be held in a dedicated, negative-pressure HD storage area — separate from the clinic's general medication stock — until administration, with signage identifying the area as HD storage.
Key Takeaways for the Exam
HDs travel within a facility in sealed, puncture-resistant secondary containers — especially liquids and injectables — routed to minimize the number of personnel and transit points involved.
Pneumatic tube systems are generally avoided for HD transport due to breakage, leak, and aerosolization risk; where used at all, they require specific validation and sealed HD-rated carriers per facility SOP.
HD storage must be physically separate from non-HD inventory, typically in a negative-pressure area with at least 12 ACPH (the nonsterile HD figure — sterile compounding buffer rooms require 30 ACPH instead).
Antineoplastic HDs are often further segregated from other HD categories within storage, per facility policy.
HD storage areas require clear signage/labeling so personnel recognize the special handling requirement at a glance.